Nanotechnology for excipients (or “nanotech”) is the use of matter on an atomic, molecular, and supramolecular scale for industrial purposes. The National Nanotechnology Initiative defined nanotechnology as the manipulation of matter with at least one dimension sized from 1 to 100 nanometers.
Pharma Excipients
Nanotechnology
Ritonavir loaded solid lipid nanoparticles for oral drug delivery and bioavailability enhancement
Abstract
Background
Ritonavir is an anti-retroviral protease inhibitor to treat HIV, AIDS infections.
Methods
The RN-SLNs were prepared by using hot homogenization followed ultrasonication method and optimized by using a two-factor, three-level central composte design (CCD). The independent…
Read More...
Read More...
Novel Carrier Systems for Targeted and Controlled Drug Delivery
Novel Carrier Systems for Targeted and Controlled Drug Delivery
See the new book, edited by Awesh K. Yadav, Keerti Jain. Here the general concepts and new research results on targeted and controlled drug delivery are examined. Challenges and future directions in controlled drug delivery are…
Read More...
Read More...
Non-Traditional Natural Stabilizers in Drug Nanosuspensions
Abstract
Poor solubility of many drugs, with ensuing low bioavailability, is a big challenge in pharmaceutical development. Nanosuspensions have emerged as a platform approach for long-acting injectables and solid dosages that enhance drug bioavailability. Despite improvements in nanosuspension…
Read More...
Read More...
Development of Dermal Lidocaine Nanosuspension Formulation by the Wet Milling Method Using…
Abstract
Lidocaine (LID), frequently used in dermal applications, is a nonpolar local anesthetic agent that is practically insoluble in water. The main aim of this study is to develop the nanosuspension formulation of LID using the design of experiments (DoE). The improved solubility and…
Read More...
Read More...
Janus Nanoparticles Loaded 3D Bio Printed Scaffold as a Dual Drug Delivery System
Abstract
Herein, a new type of controlled-release system is fabricated using polycaprolactone (PCL) and poly(lactic-co-glycolic acid) (PLGA) nanoparticles for the creation preparation study. They include doxorubicin (DOX), a standard chemical for chemotherapy, and curcumin, part of the plant…
Read More...
Read More...
A new strategy for enhancing S-Adenosyl-L-Methionine (SAMe) oral bioavailability: Preparation of…
Abstract
S-Adenosylmethionine (SAMe) is a crucial endogenous molecule in vital biochemical processes such as DNA, RNA, and protein methylation. It has been found beneficial in the treatment of liver disease, osteoarthritis, and particularly depression. However, SAMe's therapeutic potential is…
Read More...
Read More...
Aestheticizing the Self-Stabilized Pickering Emulsion of Capecitabine: Harnessing Polysarcosine…
Abstract
This study focuses on the formulation, optimization, and characterization of a water-in-oil (W/O) Pickering emulsion (PE) containing capecitabine (CAP), which is self-stabilized using polysarcosine (Psar) nanoparticles (NPs), to create a topical treatment for squamous cell carcinoma…
Read More...
Read More...
Topical Application of Dipyridamole and Roflumilast Combination Nanoparticles Loaded Nanoemulgel for…
Abstract
Background: Phosphodiesterase-4 is an enzyme that regulates immune responses and contributes to the development of psoriasis. Dipyridamole and roflumilast function as phosphodiesterase-4 inhibitors, reducing pro-inflammatory cytokine expression. The aim was to evaluate the anti-psoriatic…
Read More...
Read More...
Nanostructured lipid carriers as a strategy to enhance oral levosulpiride delivery: An in vitro and…
Abstract
Oral absorption is limited for many small-molecule drugs due to their poor aqueous solubility as well as, for some, poor membrane permeation. One such is levosulpiride (LSP), used to treat psychotic and other conditions. The present study aims to explore the effect of nanostructured…
Read More...
Read More...
Veracity of In Silico Approach for Designing Rivastigmine-Polymer Nano Complexes for Intranasal…
Abstract
Background
Rivastigmine (RT), exhibits low oral availability (40%) and high hepatic first-pass (36%). Circumventing the blood-brain barrier-related convolutions for successful brain delivery following intranasal administration prerequisites nano-size particles with high drug loading due…
Read More...
Read More...